Singapore saw the most deal activity in the last quarter. Taiwan-based Gogoro and Singapore's ASLAN Pharmaceuticals bagged the region's top deals.
VC-backed deals surged in Q4’15 in southeast Asia, totaling 71, compared to just 37 in the same quarter a year prior and 55 in Q3’15.
In the KPMG and CB Insights 2015 Venture Capital Report, we dug into global investment data including regional looks at Europe, Asia, and North America, as well as analyses of the funding climates in sub-regions like Southeast Asia.
Taiwan-based smart scooter manufacturer Gogoro bagged the top deal in Southeast Asia in the last quarter: a $130M Series B round backed by investors including Panasonic Ventures and the National Development Fund.
This was followed by Singapore-based ASLAN Pharmaceuticals’ $34M Series C round, which saw funding from investors including BioVeda Capital, Cenova Ventures, Morningside Group, and Sagamore BioVentures. (The company also raised $9M in additional funding this year.)
Singapore saw the most VC activity of any market in the region, with $89.4M invested across more than 20 deals. Malaysian startups raised $9.1M in the quarter, and Indonesian companies raised roughly $10M.
Though the number of deals increased, funding dropped almost by half in Q4’15 on a quarter-on-quarter basis, dropping from $551M in Q3’15 to $278M in Q4’15.
The average deal size in Q4’15 was only $4M, compared to $22M in Q4’14, indicative that the last quarter was marked by more frequent, but significantly smaller deals in Southeast Asia.
Want more Asian financing data? Check out our private market database below.If you aren’t already a client, sign up for a free trial to learn more about our platform.